Cardiac antibody production to self-antigens in children and adolescents during and following the correction of severe diabetic ketoacidosis

References

• Bertoni, A. G., A. Tsai, E. K. Kasper, and F. L. Brancati.2003. Diabetes and idiopathic cardiomyopathy: a nationwide case control study. Diabetes Care. 26: 2791–2795
   PubMed Web of Science ®Google Scholar
• Aragno, M., R. Mastrocola, C. Medana, et al. 2006. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology. 147: 5967–5974
   PubMed Web of Science ®Google Scholar
• Aon, M. A., C. G. Tocchetti, N. Bhatt, et al. 2015. Protective mechanisms of mitochondria and heart function in diabetes. Antioxid. Redox. Signal. 22: 1563--1586
   PubMed Web of Science ®Google Scholar
• Duncan, J. G. 2011. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim. Biophys. Acta. 1831: 1351–1359
   Web of Science ®Google Scholar
• Fillmore, N., J. Mori, and G. D. Lopaschuk. 2014. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br. J. Pharmacol. 171: 2080–2090
   PubMed Web of Science ®Google Scholar
• Palomer, X., L. Salvado, E. Barroso, and M. Vazquez-Carrera. 2013. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int. J. Cardiol. 168: 3160–3172
   PubMed Web of Science ®Google Scholar
• Robillon, J. F., J. L. Sadoul, D. Jullien, et al. 1994. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. Diabetes Metab. 20: 473–480
   Web of Science ®Google Scholar
• Kralik, P. M., G. Ye, N. S. Metreveli, et al. 2005. Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes. Cardiovasc. Toxicol. 5: 285–292
   PubMed Web of Science ®Google Scholar
• Radovits, T., S. Korkmaz, S. Loganathan, et al. 2009. Comparative investigation of the left ventricular pressure–volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am. J. Physiol. Heart Circ. Physiol. 297: H125–H133
   PubMed Web of Science ®Google Scholar
• Gotzsche, O., A. Darwish, L. Gotzsche, et al. 1996. Incipient cardiomyopathy in young insulin-dependent diabetic patients: a seven-year prospective Doppler echocardiographic study. Diabetic Med. 13: 834–840
   PubMed Web of Science ®Google Scholar
• Adal, E., G. Koyuncu, A. Aydin, et al. 2006. Asymptomatic cardiomyopathy in children and adolescents with type 1 diabetes mellitus association of echocardiographic indicators with duration of diabetes mellitus and metabolic parameters. J. Pediatr. Endocrinol. Metab. 19: 713–726
   PubMed Web of Science ®Google Scholar
• Salem, M., S. El Behery, A. Adly, et al. 2009. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr. Diabetes 10: 513–521
   PubMed Web of Science ®Google Scholar
• Carugo, S., C. Giannattasio, I. Calchera, et al. 2001. Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus. J. Hypertens 19: 1675–1680
   PubMed Web of Science ®Google Scholar
• Scibilia, J., D. Finegold, J. Dorman, et al. 1986. Why do children die? Acta. Endocrinol. Suppl. 279: 326–333
   PubMedGoogle Scholar
• Fiordalisi, I., W. E. Novotny, D. Holbert, et al. 2007. An 18-year prospective study of pediatric diabetic ketoacidosis an approach to minimize the risk of brain herniation during treatment. Pediatr. Diabetes 8: 142–149
   PubMed Web of Science ®Google Scholar
• Ceriello, A., P. delloRusso, P. Amstad, and P. Cerutti. 1996. High glucose induces antioxidant enzymes in human endothelial cells in culture – evidence linking hyperglycemia and oxidative stress. Diabetes 45: 471–477
   PubMed Web of Science ®Google Scholar
• Lee, D. M., W. H. Hoffman, G. F. Carl, et al. 2002. Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. J. Diabetes Complicat. 16: 294–300
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., C. L. Burek, J. L. Waller, et al. 2003. Cytokine response to diabetic ketoacidosis and its treatment. Clin. Immunol. 108: 175–181
   PubMed Web of Science ®Google Scholar
• Karavanavaki, K., E. Karanika, S. George, et al. 2011. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1D). Endocr. J. 58: 1045–1053
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., G. G. Passmore, D. W. Hannon, et al. 2013. Increased systemic Th 17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis. PLoS One 8: e71905
   PubMed Web of Science ®Google Scholar
• Cotter, D. G., R. C. Schugar, and P. A. Crawford. 2013. Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 304: H1060–H1076
   PubMed Web of Science ®Google Scholar
• Isales, C. M., L. Min, and W. H. Hoffman. 1999. Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J. Diabetes Complicat. 13: 91–97
   PubMed Web of Science ®Google Scholar
• Jain, S. K., and K. Kannan. 2001. Ketosis and the generation of oxygen radicals in diabetes mellitus. Diabetes Cardiovasc. Dis. Etiol. Treatment Outcomes 498: 221–227
   Google Scholar
• Hoffman, W. H., C. Cheng, G. G. Passmore, et al. 2002. Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci. Lett. 334: 71–74
   PubMed Web of Science ®Google Scholar
• Close, T. E., G. Cepinskas, T. Omatsu, et al. 2013. Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction. Microcirculation. 20: 534–543
   PubMed Web of Science ®Google Scholar
• Dalton, R. R., W. H. Hoffman, G. G. Passmore, and S. L. Martin. 2003. C-reactive protein in severe diabetic ketoacidosis. Ann. Clin. Lab. Sci. 33: 435–442
   PubMed Web of Science ®Google Scholar
• Jerath, R. S., C. L. Burek, W. H. Hoffman, and G. G. Passmore. 2005. Complement activation in diabetic ketoacidosis and its treatment. Clin. Immunol. 116: 11–17
   PubMed Web of Science ®Google Scholar
• Shapiro, J. I. 1997. Pathogenesis of cardiac dysfunction during metabolic acidosis: therapeutic implications. Kidney Int. Suppl. 61: S47–S51
   PubMedGoogle Scholar
• Swietach, P., A. Rossini, K. W. Spitzer, and R. D. Vaughan-Jones. 2007. H+ ion activation and inactivation of the ventricular gap junction: a basis for spatial regulation of intracellular pH. Circ. Res. 100: 1045–1054
   PubMed Web of Science ®Google Scholar
• Cain, B. S., D. R. Meldrum, C. A. Dinarello, et al. 1999. Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function. Crit. Care Med. 27: 1309–1318
   PubMed Web of Science ®Google Scholar
• Niu, J., M. G. Gilliland, Z. Jin, P. E. Kolattukudy, and W. H. Hoffman. 2014. MCP-1 and IL-1β expression in the myocardium of two young patients with type 1 diabetes mellitus and fatal diabetic ketoacidosis. Exp. Mol. Pathol. 96: 71–79
   PubMed Web of Science ®Google Scholar
• Oglesbee, M. J., A. V. Herdman, G. G. Passmore, and W. H. Hoffman. 2005. Diabetic ketoacidosis increases extracellular levels of the major inducible 70-kDa heat shock protein. Clin. Biochem. 38: 900–904
   PubMed Web of Science ®Google Scholar
• Zobali, F., A. Avci, O. Canbolat, and C. Karasu. 2002. Effects of vitamin A and insulin on the antioxidant state of diabetic rat heart: a comparison study with combination treatment. Cell Biochem. Funct. 20: 75–80
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., S. L. Siedlak, Y. Wang, et al. 2011. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res. 1369: 194–202
   PubMed Web of Science ®Google Scholar
• Rose, N. R. 2011. Critical cytokine pathways to cardiac inflammation. J. Interferon. Cytokine Res. 31: 705–710
   PubMed Web of Science ®Google Scholar
• Furukawa, Y., K. Kobuke, and A. Matsumori. 2001. Role of cytokines in autoimmune myocarditis and cardiomyopathy. Autoimmunity. 34: 165–168
   PubMed Web of Science ®Google Scholar
• Caforio, A. L., N. J. Mahon, F. Tona, and W. J. Mckenna. 2002. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur. J. Heart Fail. 4: 411–417
   PubMed Web of Science ®Google Scholar
• Li, H. S., D. L. Ligons, and N. R. Rose. 2008. Genetic complexity of autoimmune myocarditis. Autoimmun. Rev. 7: 168–173
   PubMed Web of Science ®Google Scholar
• Alvarez, F. L., N. Neu, N. R. Rose, et al. 1987. Heart specific autoantibodies induced by Coxsackie virus B3: identification of heart autoantigens. Clin. Immunol. Immunopathol. 43: 129–139
   PubMedGoogle Scholar
• Caforio, A. L., F. Tona, S. Bottaro, et al. 2008. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity. 41: 35–45
   PubMed Web of Science ®Google Scholar
• Morran, M. P., M. F. McInerney, and M. Pietropaolo. 2008. Innate and adaptive autoimmunity in type 1 diabetes. Pediatr. Diabetes 9: 152–161
   PubMed Web of Science ®Google Scholar
• Pino, S. C., A. J. Kruger, and R. Bortell. 2010. The role of innate immune pathways in type 1 diabetes pathogenesis. Curr. Opin. Endocrinol. Diabetes Obes. 17: 126–130
   PubMed Web of Science ®Google Scholar
• Takano, H., M. Ohtsuka, H. Akazawa, et al. 2003. Pleitropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr. Pharm. Des. 9: 1121–1127
   PubMed Web of Science ®Google Scholar
• Wu, L., S. Ong, M. V. Talor, et al. 2014. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 211: 1449–1464
   PubMed Web of Science ®Google Scholar
• Nindl, V., R. Maier, D. Ratering, et al. 2012. Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. Eur. J. Immunol. 42: 2311–2321
   PubMed Web of Science ®Google Scholar
• Shachar, I. 2013. Autoimmune disease and cytokines. J. Leukoc. Biol. 93: 51–61
   PubMed Web of Science ®Google Scholar
• Moraru, M., A. Roth, G. Keren, and J. George. 2006. Cellular autoimmunity to cardiac myosin in patients with a recent myocardial infarction. Int. J. Cardiol. 107: 61–66
   PubMed Web of Science ®Google Scholar
• Gottumukkala, R. V., H. Lv, L. Cornivelli, et al. 2012. Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes. Sci. Transl. Med. 138: 138ra80
   Google Scholar
• Castellheim, A., O. L. Brekke, T. Espevik, et al. 2009. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol. 69: 479–491
   PubMed Web of Science ®Google Scholar
• Yoshikawa, T., A. Baba, and Y. Nagatomo. 2009. Autoimmune mechanisms underlying dilated cardiomyopathy. Circ. J. 73: 602–607
   PubMed Web of Science ®Google Scholar
• Lipes, M. A., and A. Galderisi. (2015). Cardiac autoimmunity as a novel biomarker, mediator, therapeutic target of heart disease in type 1 diabetes. Curr. Diab. Rep. 15: 598
   Web of Science ®Google Scholar
• Nath, D. S., H. IIias Basha, V. Tiriveedhi, et al. 2010. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. J. Heart. Lung. Transplant. 29: 1277–1285
   PubMed Web of Science ®Google Scholar
• Yu, X., E. Patterson, S. Stavrakis, et al. 2009. Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors. J. Am. Soc. Hypertens. 3: 133–140
   PubMed Web of Science ®Google Scholar
• Nussinovitch, U., and Y. Shoenfeld. 2013. The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease. Clin. Rev. Allergy Immunol. 44: 98–108
   PubMed Web of Science ®Google Scholar
• Cole, C. R., K. E. Yutzey, A. K. Brar, et al. 2014. Congenital heart disease linked to maternal autoimmunity against cardiac myosin. J. Immunol. 192: 4074–4082
   PubMed Web of Science ®Google Scholar
• Sato, Y., A. Matsumori, and S. Sasayama. 1994. Autoantibodies against vimentin in a murine model of myocarditis. Autoimmunity. 18: 145–148
   PubMed Web of Science ®Google Scholar
• Goers, T. A., S. Ramachandran, A. Aloush, et al. 2008. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J. Immunol. 180: 4487–4494
   PubMed Web of Science ®Google Scholar
• Tiriveedhi, V., N. Angaswamy, J. Weber, and T. Mohanakumar. 2010. Lipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: role in pathogenesis of chronic rejection following human lung transplantation. Biochem. Biophys. Res. Commun. 399: 251–255
   PubMed Web of Science ®Google Scholar
• Nath, D. S., V. Tiriveedhi, H. I. Basha, et al. 2011. A role for antibodies to human leukocyte antigens, collagen-V, and K-alpha1- tubulin in antibody-mediated rejection and cardiac allograft. Transplantation. 91: 1036–1043
   PubMed Web of Science ®Google Scholar
• Ness, R. B., C. L. Haggerty, G. Harger, and R. Ferrell. 2004. Differential distribution of allelic variants in cytokine genes among African Americans and white Americans. Am. J. Epidemiol. 160: 1033–1038
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., S. M. Stamatovic, and A. V. Andjelkovic. 2009. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res. 1254: 138–148
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., C. M. Artlett, W. Zhang, et al. 2008. Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis. Brain Res. 1238: 154–162
   PubMed Web of Science ®Google Scholar
• Atabek, M. E., O. Pirgon, B. Oran, et al. 2004. Increased cardiac troponin I concentration in diabetic ketoacidosis. J. Pediatr. Endocrinol. Metab. 17: 1077–1082
   PubMed Web of Science ®Google Scholar
• Moller, N., A. C. Foss, C. H. Gravholt, et al. 2005. Myocardial injury with biomarker elevation in diabetic ketoacidosis. J. Diabetes Complicat. 19: 361–363
   PubMed Web of Science ®Google Scholar
• Nanda, S., S. Longo, S. P. Bhatt, et al. 2009. Stress cardiomyopathy-a unique presentation of diabetic ketoacidosis. Ann. Clin. Biochem. 46: 257–260
   PubMed Web of Science ®Google Scholar
• Jahns, R., V. Boivin, L. Hein, et al. 2004. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J. Clin. Invest. 113: 1419–1429
   PubMed Web of Science ®Google Scholar
• Lappe, J. M., C. M. Pelfrey, and W. H. W. Tang. (2008). Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J. Cardiac. Failure 14: 521–530
   PubMed Web of Science ®Google Scholar
• Mascaro-Blanco, A., K. Alvarez, J. Lindenfeld, et al. 2008. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity. 41: 442–453
   PubMed Web of Science ®Google Scholar
• Kukko, M., T. Kimpimaki, S. Korhonen, et al. 2005. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J. Clin. Endocrinol. Metab. 90: 2712–2717
   PubMed Web of Science ®Google Scholar
• Subramanian, V., S. Ramachandran, B. Banan, et al. 2014. Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation. Am. J. Transplant. 14: 2359–2366
   PubMed Web of Science ®Google Scholar
• Lorin De La Grandmaison, G., M. Izembart, P. Fornes, and F. Paraire. 2003. Myocarditis associated with Hashimoto’s disease: a case report. Int. J. Legal Med. 117: 361–364
   PubMed Web of Science ®Google Scholar
• Schumann, C., M. Faust, M. Gerharz, et al. 2005. Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. Exp. Clin. Endocrinol. Diabetes 113: 302–307
   PubMed Web of Science ®Google Scholar
• Mavrogeni, S., K. Spargias, V. Markussis, et al. 2009. Myocardial inflammationin autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm. Allergy Drug. Targets. 8: 390–397
   PubMedGoogle Scholar
• Rose, N. R., J. H. Kite, T. K. Doebbler, et al. 1965. Studies on experimental thyroiditis. Ann. N. Y. Acad. Sci. 124: 201–230
   PubMed Web of Science ®Google Scholar
• Burek, C. L., N. R. Rose, K. E. Guire, and W. H. Hoffman. 1990. Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity. 7: 157–167
   PubMed Web of Science ®Google Scholar
• Kohn, L. D., K. Suzuki, W. H. Hoffman, et al. 1997. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto’s patient whose children had intrauterine and neonatal thyroid disease. J. Clin. Endocrinol. Metab. 82: 3998–4009
   PubMed Web of Science ®Google Scholar
• Kawasaki, E. 2014. Type 1 diabetes and autoimmunity. Clin. Pediatr. Endocrinol. 23: 99–105
   PubMedGoogle Scholar
• Magnani, J. W., and G. W. Dec. 2006. Myocarditis: current trends in diagnosis and treatment. Circulation. 113: 876–890
   PubMed Web of Science ®Google Scholar
• Wojcik, M., A. Rudzinski, and J. Starzyk. 2010. Left ventricular diastolic dysfunction in adolescents with type 1 diabetes reflects the long-but not short metabolic control. J. Pediatr. Endocrinol. Metab. 23: 1055–1064
   PubMed Web of Science ®Google Scholar
• Moller, N., A. C. Foss, C. H. Gravholt, et al. 2005. Myocardial injury with biomarker elevation in diabetic ketoacidosis. J. Diabetes Complicat. 19: 361–363
   PubMed Web of Science ®Google Scholar
• Goser, S., M. Andrassy, S. J. Buss, et al. 2006. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114: 1693–1702
   PubMed Web of Science ®Google Scholar
• Sima, A. A., W. Zhang, O. Muzik, et al. 2009. Sequential abnormalities in type 1 diabetic encephalopathy and the effects of c-peptide. Rev. Diabet. Stud. 6: 211–222
   PubMedGoogle Scholar
• Hoffman, W. H., F. Kappler, G. G. Passmore, and R. Mehta. 2003. Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone. Clin. Biochem. 36: 269–273
   PubMed Web of Science ®Google Scholar
• Turk, Z., I. Nemet, L. Varga-Defteardarovic, and N. Car. 2006. Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase. Diabetes Metab. 32: 176–180
   PubMed Web of Science ®Google Scholar
• Brouwers, O., J. M. de Vos-Houben, P. M. Niessen, et al. 2013. Mild oxidative damage in the diabetic rat heart is attenuated by glyoxalase-1 overexpression. Int. J. Mol. Sci. 14: 15724–15739
   PubMed Web of Science ®Google Scholar
• Gonzalez, I., J. Romero, B. L. Rodriguez, et al. 2013. The immunobiology of the receptor of advanced glycation end-products: trends and challenges. Immunobiology. 218: 790–797
   PubMed Web of Science ®Google Scholar
• Sveen, K. A., T. Nerdrum, K. F. Hanssen, et al. 2014. Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: associations with protein glycation. Diab. Vasc. Dis. Res. 11: 84–91
   PubMed Web of Science ®Google Scholar
• Ma, H., S. Y. Li, S. A. Babcock, et al. 2009. Advanced glycation endproducts (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J. Cell Mol. Med. 8B: 1751–1764
   Web of Science ®Google Scholar
• Emamaullee, J. A., J. Davis, S. Merani, et al. 2009. Inhibition of Th17 cells regulate autoimmune diabetes in NOD mice. Diabetes 58: 1302–1311
   PubMed Web of Science ®Google Scholar
• Nindl, V., R. Maier, D. Ratering, et al. 2012. Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. Eur. J. Immmunol. 42: 2311–2321
   PubMed Web of Science ®Google Scholar
• Ahn, J., and J. Kim. 2012. Mechanisms and consequences of inflammatory signaling in the myocardium. Curr. Hypertens. Rep. 14: 510–516
   PubMed Web of Science ®Google Scholar
• Zimmermann, O., M. Bienek-Ziolkowski, B. Wolf, et al. 2009. Myocardial inflammation and non-ischaemic heart failure: is there a role for C-reactive protein? Basic Res. Cardiol. 104: 591–599
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., C. D. Cudrici, E. Zafranskaia, and H. Rus. 2006. Complement activation in diabetic ketoacidosis brains. Exp. Mol. Pathol. 80: 283–288
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., M. F. Casanova, C. D. Cudrici, et al. 2007. Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis. Exp. Mol. Pathol. 83: 65–72
   PubMed Web of Science ®Google Scholar
• Frangogiannis, N. G. 2008. The immune system and cardiac repair. Pharmacol. Res. 58: 88–111
   PubMed Web of Science ®Google Scholar
• Frangogiannis, N. G. 2012. Regulation of the inflammatory response in cardiac repair. Circ. Res. 110: 159–173
   PubMed Web of Science ®Google Scholar
• Zwaka, T. P., D. Manolov, C. Ozdemir, et al. 2002. Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes. Am. J. Pathol. 161: 449–457
   PubMed Web of Science ®Google Scholar
• Costello, J. P., T. Mohanakumar, and D. S. Nath. 2013. Mechanisms of chronic cardiac allograft rejection. Tex. Heart Inst. J. 40: 395–399
   PubMed Web of Science ®Google Scholar
• Bonvini, R. F., T. Hendiri, and E. Camenzind. 2005. Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target? Eur. Heart J. 7: 127–136
   Web of Science ®Google Scholar
• Fairweather, D. L., and N. R. Rose. 2007. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods. 41: 118–122
   PubMed Web of Science ®Google Scholar
• Dec, G. W., I. Palacios, T. Yasuda, et al. 1990. Anitimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J. Am. Coll. Cardiol. 16: 97–104
   PubMed Web of Science ®Google Scholar
• Sochett, E., and D. Daneman. 1999. Early diabetes-related complications in children and adolescents with type 1 diabetes. Implications for screening and intervention. Endocrinol. Metab. Clin. North Am. 28: 865–882
   PubMed Web of Science ®Google Scholar
• Salem, M., S. El Behery, A. Adly, et al. 2009. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr. Diabetes 10: 513–521
   PubMed Web of Science ®Google Scholar